The impact of natural history parameters on the cost-effectiveness of Chlamydia trachomatis screening strategies

被引:16
|
作者
Hu, Delphine
Hook, Edward W., III
Goldie, Sue J.
机构
[1] Harvard Univ, Sch Publ Hlth, Dept Hlth Policy & Management, Initiat Global Hlth, Cambridge, MA 02138 USA
[2] Univ Alabama Birmingham, Birmingham, AL USA
关键词
D O I
10.1097/01.olq.0000200577.46261.b0
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
Objective/Goal: To understand the potential impact of assumptions about the natural history of untreated Chlamydia trachomatis on the cost-effectiveness of screening strategies. Study Design: Using a previously developed state-transition model, we explored how alternative assumptions about the natural history of disease following infection affect the estimated cost-effectiveness of screening for U.S. women. The analysis was conducted from a modified societal perspective and incorporated a lifetime analytic horizon. Results: Different natural history assumptions affect cost-effectiveness outcomes. Assumptions about the combined risk of persistent and repeat infections have the greatest impact on the composition of optimal screening strategies, whereas assumptions about the risk of pelvic inflammatory disease most greatly influenced the magnitude of incremental cost-effectiveness ratios. Conclusions: Priorities for future C trachomatis research should include better estimates of the risk of pelvic inflammatory disease, persistence, and repeat infection. Better delineation of these variables will permit improved evaluation of potential screening activities.
引用
收藏
页码:428 / 436
页数:9
相关论文
共 50 条
  • [1] Cost-effectiveness of two screening strategies for Chlamydia Trachomatis infections in France
    Préaubert, N
    Delaveyne, R
    VALUE IN HEALTH, 2003, 6 (06) : 758 - 758
  • [2] The cost and cost-effectiveness of opportunistic screening for Chlamydia trachomatis in Ireland
    Gillespie, Paddy
    O'Neill, Ciaran
    Adams, Elisabeth
    Turner, Katherine
    O'Donovan, Diarmuid
    Brugha, Ruairi
    Vaughan, Deirdre
    O'Connell, Emer
    Cormican, Martin
    Balfe, Myles
    Coleman, Claire
    Fitzgerald, Margaret
    Fleming, Catherine
    SEXUALLY TRANSMITTED INFECTIONS, 2012, 88 (03) : 222 - 228
  • [3] Cost-effectiveness of a pharmacy-based screening for Chlamydia trachomatis
    van Bergen, JE
    Postma, MJ
    Peerbooms, PG
    Spangenberg, AC
    Tjen-A-Tak, J
    Bindels, PJ
    VALUE IN HEALTH, 2003, 6 (06) : 754 - 755
  • [4] Epidemiology of Chlamydia trachomatis infection in women and the cost-effectiveness of screening
    Land, J. A.
    Van Bergen, J. E. A. M.
    Morre, S. A.
    Postma, M. J.
    HUMAN REPRODUCTION UPDATE, 2010, 16 (02) : 189 - 204
  • [5] The Cost-Effectiveness of Screening Men for Chlamydia trachomatis: A Review of the Literature
    Gift, Thomas L.
    Blake, Diane R.
    Gaydos, Charlotte A.
    Marrazzo, Jeanne M.
    SEXUALLY TRANSMITTED DISEASES, 2008, 35 (11) : S51 - S60
  • [6] COST-EFFECTIVENESS OF SCREENING FOR CHLAMYDIA TRACHOMATIS IN DUTCH PREGNANT WOMEN
    Rours, G. I. J. G.
    Verkooijen, R. P.
    Verbrugh, H. A.
    Postma, M. J.
    SEXUALLY TRANSMITTED INFECTIONS, 2011, 87 : A61 - A61
  • [7] COST-EFFECTIVENESS OF PRE-NATAL SCREENING FOR CHLAMYDIA TRACHOMATIS
    NETTLEMAN, MD
    CLINICAL RESEARCH, 1988, 36 (06): : A874 - A874
  • [8] Improving the cost-effectiveness of Chlamydia screening with targeted screening strategies
    Evenden, D.
    Harper, P. R.
    Brailsford, S. C.
    Harindra, V.
    JOURNAL OF THE OPERATIONAL RESEARCH SOCIETY, 2006, 57 (12) : 1400 - 1412
  • [9] Dynamic modelling for estimating the cost-effectiveness of a Chlamydia trachomatis screening program
    de Vries, R.
    van Bergen, J. E. A. M.
    de Jong-van den Berg, L. T. W.
    Postma, M. J.
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2006, 62 (06) : 736 - 736
  • [10] Cost-effectiveness analysis of Chlamydia trachomatis screening in Dutch pregnant women
    Rours, G. I. J. G.
    Smith-Norowitz, Tamar Anne
    Ditkowsky, Jared
    Hammerschlag, Margaret R.
    Verkooyen, R. P.
    de Groot, R.
    Verbrugh, H. A.
    Postma, M. J.
    PATHOGENS AND GLOBAL HEALTH, 2016, 110 (7-8) : 292 - 302